Regressed melanocytic nevi secondary to pembrolizumab therapy: an emerging melanocytic dermatologic effect from immune checkpoint antibody blockade

Shakuntala H. Mauzo, Michael T. Tetzlaff, Kelly Nelson, Rodabe Amaria, Sapna Patel, Phyu P. Aung, Priyadharsini Nagarajan, Carlos A. Torres-Cabala, Adi Diab, Victor G. Prieto, Jonathan L. Curry

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Regressed melanocytic nevi secondary to pembrolizumab therapy: an emerging melanocytic dermatologic effect from immune checkpoint antibody blockade'. Together they form a unique fingerprint.

Medicine & Life Sciences